Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins

Journal of Virological Methods

Volumn 174, Issue 1-2, 2011, Pages 99-109

  Ou, Wu ^a   Delisle, Josie ^a   Konduru, Krishnamurthy ^a   Bradfute, Steven ^b   Radoshitzky, Sheli R ^b   Retterer, Cary ^b   Kota, Krishna ^b   Bavari, Sina ^b   Kuhn, Jens H ^c   Jahrling, Peter B ^c   Kaplan, Gerardo ^a   Wilson, Carolyn A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Ebola; Ebolavirus; Envelope glycoprotein; Filovirus; SGP

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; BUNDIBUGYO VIRUS; CELL STRAIN HEK293; CONTROLLED STUDY; CROSS REACTION; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FILOVIRIDAE; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOTYPING; RABBIT; RESTON VIRUS; SUDAN VIRUS; TAI FOREST VIRUS; VERO CELL; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMORRHAGIC FEVER, EBOLA; MICE; RABBITS; VIRAL ENVELOPE PROTEINS; VIROLOGY;

EBOLA VIRUS; MARBURGVIRUS; MUS; ORYCTOLAGUS CUNICULUS; PRIMATES;

EID: 79955756488     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.04.003     Document Type: Article

References (25)

1. Dolnik O., Kolesnikova L., Becker S. Filoviruses: interactions with the host cell. Cell Mol. Life Sci. 2008, 65:756-776.
2. Feldmann H., Jones S., Klenk H.D., Schnittler H.J. Ebola virus: from discovery to vaccine. Nat. Rev. Immunol. 2003, 3:677-685.
3. Feldmann H., Volchkov V.E., Volchkova V.A., Klenk H.D. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch. Virol. Suppl. 1999, 15:159-169.
4. Gupta M., Mahanty S., Bray M., Ahmed R., Rollin P.E. Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 2001, 75:4649-4654.
5. Huang Y., Gu B., Wu R., Zhang J., Li Y., Zhang M. Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells. Hybridoma (Larchmt) 2007, 26:387-391.
6. Jahrling P.B., Geisbert J., Swearengen J.R., Jaax G.P., Lewis T., Huggins J.W., Schmidt J.J., LeDuc J.W., Peters C.J. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 1996, 11:135-140.
7. Konduru K., Bradfute S.B., Jacques J., Manangeeswaran M., Nakamura S., Morshed S., Wood S.C., Bavari S., Kaplan G.G. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine 2011, 10.1016/j.vaccine.2011.01.113.
8. Kovaleva E.S., O'Connell K.P., Buckley P., Liu Z., Davis D.C. Recombinant protein production in insect larvae: host choice, tissue distribution, and heterologous gene instability. Biotechnol. Lett. 2009, 31:381-386.
9. Kuhn J.H., Becker S., Ebihara H., Geisbert T.W., Johnson K.M., Kawaoka Y., Lipkin W.I., Negredo A.I., Netesov S.V., Nichol S.T., Palacios G., Peters C.J., Tenorio A., Volchkov V.E., Jahrling P.B. Proposal for a revised taxonomy of the family Filoviridae - classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 2010, 155:2083-2103.
10. Kuhn J.H., Radoshitzky S.R., Guth A.C., Warfield K.L., Li W., Vincent M.J., Towner J.S., Nichol S.T., Bavari S., Choe H., Aman M.J., Farzan M. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J. Biol. Chem. 2006, 281:15951-15958.
11. Lee J.E., Fusco M.L., Hessell A.J., Oswald W.B., Burton D.R., Saphire E.O. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008, 454:177-182.
12. Lucht A., Grunow R., Otterbein C., Moller P., Feldmann H., Becker S. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med. Microbiol. Immunol. 2004, 193:181-187.
13. Mpanju O.M., Towner J.S., Dover J.E., Nichol S.T., Wilson C.A. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res. 2006, 121:205-214.
14. Ou W., King H., Delisle J., Shi D., Wilson C.A. Phenylalanines at positions 88 and 159 of Ebolavirus envelope glycoprotein differentially impact envelope function. Virology 2010, 396:135-142.
15. Parren P.W., Geisbert T.W., Maruyama T., Jahrling P.B., Burton D.R. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J. Virol. 2002, 76:6408-6412.
16. Sanchez A., Trappier S.G., Mahy B.W., Peters C.J., Nichol S.T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3602-3607.
17. Shahhosseini S., Das D., Qiu X., Feldmann H., Jones S.M., Suresh M.R. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J. Virol. Methods 2007, 143:29-37.
18. Takada A., Ebihara H., Jones S., Feldmann H., Kawaoka Y. Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 2007, 25:993-999.
19. Towner J.S., Sealy T.K., Khristova M.L., Albarino C.G., Conlan S., Reeder S.A., Quan P.L., Lipkin W.I., Downing R., Tappero J.W., Okware S., Lutwama J., Bakamutumaho B., Kayiwa J., Comer J.A., Rollin P.E., Ksiazek T.G., Nichol S.T. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008, 4:e1000212.
20. Volchkov V.E. Processing of the Ebola virus glycoprotein. Curr. Top. Microbiol. Immunol. 1999, 235:35-47.
21. Volchkov V.E., Becker S., Volchkova V.A., Ternovoj V.A., Kotov A.N., Netesov S.V., Klenk H.D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995, 214:421-430.
22. Volchkova V.A., Feldmann H., Klenk H.D., Volchkov V.E. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 1998, 250:408-414.
23. Wilson J.A., Hevey M., Bakken R., Guest S., Bray M., Schmaljohn A.L., Hart M.K. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000, 287:1664-1666.
24. Yang Z., Delgado R., Xu L., Todd R.F., Nabel E.G., Sanchez A., Nabel G.J. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 1998, 279:1034-1037.
25. Yu J.S., Liao H.X., Gerdon A.E., Huffman B., Scearce R.M., McAdams M., Alam S.M., Popernack P.M., Sullivan N.J., Wright D., Cliffel D.E., Nabel G.J., Haynes B.F. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J. Virol. Methods 2006, 137:219-228.